‘Breakthrough’ Summit In Bangkok: Transforming Cancer Care

Cancer
Print icon
By Jo Cavallo
American Society of Clinical Oncology (ASCO)

Dr. Peter Yu, physician-in-chief of the Hartford HealthCare Cancer Institute, is planning a new approach at the American Society of Clinical Oncology’s first international meeting, Breakthrough: A Global Summit for Oncology Innovators Oct. 11-13 in Bangkok, Thailand. Dr. Yu, past president of ASCO, is co-host/committee chair of the Breakthrough meeting.

The meeting is a joint effort by ASCO and the Thai Society of Clinical Oncology to bring together leaders in a variety of disparate fields, including information and computer science, artificial intelligence, basic and translational research, social media and biomedical engineering, to transform oncology care delivery and explore how technology will influence cancer care in the coming years.

“We wanted a meeting that was engaging and exciting and instead of looking back at the past year,” said Dr. Yu, “which is what a traditional medical meeting does, look forward to ask where are we going in the field of oncology? What innovation is already in development that will transform how we treat patients with cancer, how we educate our members and how we conduct research?”

Currently, topics for the Breakthrough meeting include How Technology Will Shape the Future of Cancer Care; the Next Generation of Immunotherapy; Novel and Research Strategies Through Social Networks and Telecommunications; AI in Oncology and Therapeutics; The Use of Technology and Biochemical Markers for Diagnosis and Surveillance; New Diagnostics; Microbiota, Immune-Tonus, and Cancer; The Postgenomic Condition: Ethics, Justice, and Knowledge After the Genome; New Molecular and Immuno-Oncologic-based Therapeutics; Robotic Surgery; and Personalized Vaccines.

The meeting will feature speakers from the United States, Asia, and Europe, including Philip Greenberg, MD, Head of Immunology at Fred Hutchinson Cancer Research Center in Seattle; Gilberto Lopes, MD, MBA, FASCO, Associate Professor of Clinical Medicine at the University of Miami, Editor-in-Chief of ASCO’s Journal of Global Oncology, and Co-Chair of the Organizing Committee for the Breakthrough meeting; Tony S.K. Mok, MD, FRCPC, FASCO, Li Shu Fan Medical Foundation Named Professor of Clinical Oncology and Chair of Clinical Oncology at The Chinese University of Hong Kong, and Breakthrough Program Committee Chair; and Vivian Li, PhD, Group Leader at the Francis Crick Institute in London.

For more information on Breakthrough: A Global Summit for Oncology Innovators Oct. 11-13 in Bangkok, Thailand, click here.

For more information on the Hartford HealthCare Cancer Institute, click here.

 


What's New

Pancreatic Cancer

Free Pancreatic Care Webinar June 11

The fourth leading cause of cancer death in both men and women, pancreatic cancer, is an aggressive form of the disease that often exhibits few symptoms until it is advanced. Approximately 57,000 Americans will be diagnosed with it this year, according to the American Cancer Society. About 47,000 will die...

Jeffrey A. Flaks

A Message From Hartford HealthCare CEO Jeffrey Flaks

With the concerns about coronavirus and COVID-19, I want to assure you that Hartford HealthCare is doing everything possible to protect the safety and well-being of the people and the communities we serve, and our team of healthcare providers. Our goal is to be ready and prepared for whatever is...

Quite Smoking

Trying to Quit Smoking? Here’s Some Help

Editor’s note: Initial studies have shown that if you smoke and get COVID-19, you’re 14 times more likely than nonsmokers to require intensive treatment. If you’ve considered stopping smoking, now is a good time. By Ellen Anderson Dornelas, PhD Director, Cancer Care Delivery and Disparities Research Hartford Healthcare Cancer Institute...

Pancreatic Cancer Recovery

How to Manage Pancreatic Cancer Treatment’s Side Effects

A pancreatic cancer survivor is any person who is actively facing pancreatic cancer or has faced it at some point. It could be someone who has completed treatment or a patient actively receiving chemotherapy for a limited or long-term management of their disease. Patients treated with chemotherapy experience a variety...

Breast Cancer Awareness

The New Normal for Breast Cancer Survivors

The word “patient” stems from the Latin word patiens, meaning sufferer. Until recently, a diagnosis of cancer conveyed a sense of victimhood and loss of control, hence labels such as “cancer patient” or “cancer victim.” Despite good intentions, these terms left those with a cancer diagnosis feeling isolated and somehow...